News Briefs
- 4/24/2022
Grande Cosmetics rolls out eyeliner with lash enhancing serum
Grande Cosmetics is helping consumers obtain their best natural lashes yet with a new liquid eyeliner that contains the same actives as its GrandeLash-MD.
The GrandeLiner Liquid Eyeliner with Lash Enhancing Serum contains amino acid L-proline to help users obtain healthy and fortified lashes; as well as hyaluronic acid to condition and protect while also preventing breakage and hydrating dry, brittle or damaged lashes; and vitamin E to support lash health, the company said.
Available in a black color that contains a 12-hour wear and is water-resistant, the eyeliner does not feather, smudge or flake, features a precision brush for control, stays in place, and is made with a cruelty-free formula.
Currently, GrandeLiner Liquid Eyeliner with Lash Enhancing Serum is available for purchase exclusively at Sephora and GrandeCosmetics.com for the suggested retail price of $40.
- 4/24/2022
L’il Critters debuts melatonin supplement
L’il Critters has launched a brand-new supplement designed to help children achieve a restful night’s sleep.
The Ewing, N.J.-based company’s latest melatonin gummy was designed to work naturally with children’s bodies, regulate sleep cycles and contains such ingredients as passionflower, chamomile and lemon balm
Available in a natural plump peach flavor, each serving is made with 1.5 mg of melatonin for sleep support and does not contain high fructose corn syrup, synthetic FD&C dyes, artificial flavors, gluten, dairy or sugar, the company said.
“It’s important for kids to live an active and healthy lifestyle, while also getting a decent night’s sleep,” said John Bullock, brand manager at L’il Critters™ Gummy Vitamin Brand. “We created L’il Critters Melatonin to help kids by providing sleep support and are confident that kids and parents alike will enjoy this yummy new gummy.”
Currently, L’il Critters Melatonin gummies are available for purchase online at Target.com.
- 4/24/2022
GoodPop intros gluten-free oatmilk frozen dessert
GoodPop is unveiling a new addition to its better-for-you frozen treat portfolio.
The latest launch from the Austin, Texas-based company is its line of plant-based and gluten-free frozen dessert sandwiches.
“With plant-based novelties being the fastest growing segment in the ice cream category and consumer feedback showing demand for better for you frozen desserts, the time was right to take our philosophy and elevated sourcing standards to expand beyond the pop and create our version of an ice cream sandwich as we continue to redefine the frozen novelties category,” said Rahul Shah, president and chief operating officer of GoodPop.
Available in a chocolate vanilla sandwich variety, each contains 100 calories and 8 g of sugar per serving, is kosher, and made with only fair trade and non-GMO ingredients, the company said.
“We love reinventing classic nostalgic favorites with better-for-you ingredients, which means they have a much shorter, better-for-you ingredient list and are allergen-friendly, but without sacrificing taste,” said Daniel Goetz, CEO and founder of GoodPop. “We decided to enter new territory because we saw an opportunity in the market to recreate the cult classic ice cream sandwiches like the ones we grew up with in the ‘80s and ‘90s, but with cleaner ingredients that are more delicious and better for people and the planet. We’re proud of the result with our Chocolate Vanilla Sandwiches as we continue our mission of using frozen treats as a vehicle to do social and environmental good through our Pledge Good Foundation.”
GoodPop plant-based and gluten-free frozen chocolate vanilla sandwich retails from $4.99 to $5.99 and can be found at such retailers as Whole Foods Market, Sprouts, H-E-B, Gelson’s, Raley’s and online at goodpops.com.
- 4/22/2022
Halo Top debuts chocolate flavor, reformulates recipe
Halo Top recently announced that it will be launching a brand new flavor — chocolate cake batter.
Featuring a chocolatey cake batter light ice cream with colored sprinkles, this new variant comes in a pint that contains 330 calories, according to the Le Mars, Iowa-based company.
In addition, the brand shared that it made a change to its Dairy Light Ice Cream recipe to feature a creamier texture while also maintaining the same taste and low calories it has become synonymous for.
“Throughout 2022, our fans can now enjoy their favorite Halo Top Dairy Light Ice Cream flavors with even creamier texture thanks to our latest reformulation. The new recipe will give fans all the delicious taste they know and love from Halo Top with an increase in creaminess,” said Pete Gargula, Halo Top brand manager.
Consumers can find Halo Top’s new chocolate cake batter light cream in the frozen aisle of grocery stores nationwide for the suggested retail price of $4.99 and a “now creamier” label on its packaging to indicate the revamped recipe.
- 4/21/2022
Finishing Touch Flawless Bikini assists with personal grooming needs
Finishing Touch Flawless is continuing to expand its offerings with a brand-new tool designed to gently remove unwanted hair from the bikini area.
The Finishing Touch Flawless Bikini tool features thoughtful innovation and a modern design, and comes in a discreet and portable format that allows for a convenient fit anywhere, the company said.
Featuring a built-in LED spotlight to illuminate the skin while shaving, no downtime or recovery is needed after using, which allows for convenient usage when compared to waxing or lasering, according to the brand.
Designed with an angled head for hard-to-reach areas, this pain-free beauty tool is gentle on all skin types and retails for $19.99 at Ulta Beauty.
- 4/22/2022
Hikma acquires Custopharm
Hikma has completed its acquisition of Custopharm from Water Street Healthcare Partners, following approval from the Federal Trade Commission.
As previously announced on Sept. 27, 2021, the company acquired Custopharm for an initial cash consideration of $375 million on a debt and cash-free basis, with a further $50 million in contingent consideration payable upon the achievement of certain commercial milestones.
Hikma noted that the company is the second-largest supplier by volume of generic sterile injectable medicines used by US hospitals and health care providers. The combination with Custopharm enhances Hikma’s R&D capabilities and pipeline and expands Hikma’s differentiated U.S. portfolio to close to 130 commercialized injectable medicines — a more than fivefold increase over the last decade.
In addition, the company shared that the acquisition complements its product portfolio and pipeline, adding up to 13 approved products and additional pipeline products, and enhances R&D capabilities, adding an experienced scientific team of dedicated R&D professionals with a proven ability to develop and commercialize complex sterile injectable products and a state-of-the-art R&D laboratory in California.
The acquisition also maintains Hikma’s strong regulatory track record. Custopharm has consistently obtained regulatory approval for new products with four first-to-market FDA ANDA approvals, including one CGT exclusivity for Calcitonin Salmon, which was launched in May 2021.
“The acquisition of Custopharm immediately strengthens our already strong U.S. injectables business by adding an attractive and profitable portfolio of marketed products, an exciting pipeline of future opportunities and a first-class scientific team with a strong regulatory track record," said Hikma CEO Siggi Olafsson. “This acquisition is highly complementary to our existing business and places us in an excellent position to better serve the growing needs of hospitals, doctors and patients. I am excited to welcome the team at Custopharm to Hikma as we continue to grow and strengthen our injectables business.”